Lee AL, et al. Distractive auditory stimuli in the form of music in individuals with chronic obstructive pulmonary disease: A systematic review. Chest. 2015. doi:10.1378/chest.14-2168
Vali Y, et al. Investigating and managing suspected pulmonary embolism in an outpatient setting: the Leicester experience. Thorax. 2015 Mar;70(3):291–3.
Informations de la FDA concernant la prescription du nivolumab
Rizvi N, Mazières J, et al. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Thelancet, Volume 16, No. 3, p257–265, March 2015
Boeree MJ, et al. A Dose Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis. Am J Respir Crit Care Med. 2015 Feb 5;
Dorman SE, et al. Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial. Am J Respir Crit Care Med. 2015 Feb 1;191(3):333–43.
Corris PA, et al. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax. 2015 Feb 24;thoraxjnl – 2014–205998